Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Buyer: | CELL AND GENE THERAPY CATAPULT |
| Main Category: | Services |
| Procurement Method: | Open procedure |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 13 September 2022 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-034db7 |
| Notice Reference: | 025600-2022 |
Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector.Human cells will be subjected to AAV production in parallel with controls. A range of samples (between 21 and 35) will be generated in this experiment, designated as "Run 1". The samples will then be processed by the awarded Bidder. In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 35 samples will be obtained for either "Run 2" and "Run 3".
Premarket Engagement for the Future Purchase of a Liquid Chromatography-Mass Spectrometer
CELL AND GENE THERAPY CATAPULT · WAC-154705
Premarket Engagement for the Future Purchase of a Fluorescence Activated Cell Sorter (FACS) Instrument and Associated Post Installation Services
CELL AND GENE THERAPY CATAPULT · WAC-183546
Premarket Engagement Specification for Custom column packing service (cGMP and non-cGMP grade)
CELL AND GENE THERAPY CATAPULT · WAC-183565
Pipeline status
Not addedContract imported automatically · AI writes the response
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →